GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PT UBC Medical Indonesia Tbk (ISX:LABS) » Definitions » EBIT

PT UBC Medical Indonesia Tbk (ISX:LABS) EBIT : Rp Mil (TTM As of . 20)


View and export this data going back to 2024. Start your Free Trial

What is PT UBC Medical Indonesia Tbk EBIT?

PT UBC Medical Indonesia Tbk's earnings before interest and taxes (EBIT) for the six months ended in . 20 was Rp0.00 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.


PT UBC Medical Indonesia Tbk EBIT Historical Data

The historical data trend for PT UBC Medical Indonesia Tbk's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT UBC Medical Indonesia Tbk EBIT Chart

PT UBC Medical Indonesia Tbk Annual Data
Trend
EBIT

PT UBC Medical Indonesia Tbk Semi-Annual Data
EBIT

Competitive Comparison of PT UBC Medical Indonesia Tbk's EBIT

For the Medical Devices subindustry, PT UBC Medical Indonesia Tbk's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT UBC Medical Indonesia Tbk's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PT UBC Medical Indonesia Tbk's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PT UBC Medical Indonesia Tbk's EV-to-EBIT falls into.



PT UBC Medical Indonesia Tbk EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in . 20 was Rp Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT UBC Medical Indonesia Tbk  (ISX:LABS) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

PT UBC Medical Indonesia Tbk's annualized ROC % for the quarter that ended in . 20 is calculated as:

ROC % (Q: . 20 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: . 20 ) + Invested Capital (Q: . 20 ))/ count )
= * ( 1 - % )/( ( + )/ )
=/
= %

where

Note: The Operating Income data used here is one times the annual (. 20) data.

2. Joel Greenblatt's definition of Return on Capital:

PT UBC Medical Indonesia Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

ROC (Joel Greenblatt) %(Q: . 20 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: . 20  Q: . 20
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=/( ( ( + max(, 0)) + ( + max(, 0)) )/ )
=/( ( + )/ )
=/
= %

where Working Capital is:

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

Working Capital(Q: . 20 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=( + + ) - ( + + )
=

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (. 20) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

PT UBC Medical Indonesia Tbk's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: . 20 )
=/549050.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PT UBC Medical Indonesia Tbk EBIT Related Terms

Thank you for viewing the detailed overview of PT UBC Medical Indonesia Tbk's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


PT UBC Medical Indonesia Tbk Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Jalan Rawagelam V, Pulogadung Industrial Area, Block L, No. Kav 11-13, East Jakarta, Jatinegara Subdistrict, Cakung District,, Jakarta, IDN
PT UBC Medical Indonesia Tbk is a distributor of medical devices. Its product include NeumoDx, Airdoc Retina AI, QIAstat-Dx, PCR, etc.

PT UBC Medical Indonesia Tbk Headlines